usamicro_0194|CATB|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
usamicro_0194|CATB|1|Catabasis Pharmaceuticals Inc Total Current Assets (Quarterly) (USD)|Catabasis Pharmaceuticals Inc Cash and Short Term Investments (Quarterly) (USD)|Catabasis Pharmaceuticals Inc Inventories (Quarterly) (USD)|Catabasis Pharmaceuticals Inc Net PP&E (Quarterly) (USD)|Catabasis Pharmaceuticals Inc Goodwill and Intangibles (Quarterly) (USD)|Catabasis Pharmaceuticals Inc Total Liabilities (Quarterly) (USD)|Catabasis Pharmaceuticals Inc Total Current Liabilities (Quarterly) (USD)|Catabasis Pharmaceuticals Inc Total Long Term Liabilities (Quarterly) (USD)|Catabasis Pharmaceuticals Inc Total Deposits (Quarterly) (USD)|Catabasis Pharmaceuticals Inc Book Value (Quarterly) (USD)|Catabasis Pharmaceuticals Inc Retained Earnings (Quarterly) (USD)|Catabasis Pharmaceuticals Inc Treasury Stock (Quarterly) (USD)|Catabasis Pharmaceuticals Inc EV to Revenues|Catabasis Pharmaceuticals Inc EV to Earnings|Catabasis Pharmaceuticals Inc EV to Free Cash Flow|Catabasis Pharmaceuticals Inc EV to Assets (Quarterly)|Catabasis Pharmaceuticals Inc PS Ratio|Catabasis Pharmaceuticals Inc PE Ratio|Catabasis Pharmaceuticals Inc Price to Book Value|Catabasis Pharmaceuticals Inc PEG Ratio|Catabasis Pharmaceuticals Inc Debt to Equity Ratio|Catabasis Pharmaceuticals Inc Dividend Yield|Catabasis Pharmaceuticals Inc Shareholder Yield (TTM)|Catabasis Pharmaceuticals Inc Percent of Shares Outstanding Short|Catabasis Pharmaceuticals Inc Total Receivables (Quarterly) (USD)|Catabasis Pharmaceuticals Inc Total Payables (Quarterly) (USD)|Catabasis Pharmaceuticals Inc Total Capital Stock (Quarterly) (USD)|Catabasis Pharmaceuticals Inc Return on Invested Capital|Catabasis Pharmaceuticals Inc Quality Ratio Score|Catabasis Pharmaceuticals Inc Momentum Score|Catabasis Pharmaceuticals Inc Beta (1Y)|Catabasis Pharmaceuticals Inc Sustainable Growth Rate (TTM)|Catabasis Pharmaceuticals Inc Institutional Investor Ownership Percentage|Catabasis Pharmaceuticals Inc Average Diluted Shares Outstanding (Quarterly)|Catabasis Pharmaceuticals Inc Total Employees (Annual)|Catabasis Pharmaceuticals Inc EPS Diluted (Quarterly) (USD)|Catabasis Pharmaceuticals Inc Shares Outstanding|Catabasis Pharmaceuticals Inc Repurchase of Capital Stock (Quarterly) (USD)|Catabasis Pharmaceuticals Inc Ordinary Shares Number (Quarterly)|Catabasis Pharmaceuticals Inc Payout Ratio|Catabasis Pharmaceuticals Inc Quick Ratio (Quarterly)|Catabasis Pharmaceuticals Inc Normalized Diluted EPS (Quarterly) (USD)|Catabasis Pharmaceuticals Inc Stock Buybacks (Quarterly) (USD)|Catabasis Pharmaceuticals Inc Effective Tax Rate (TTM)|Catabasis Pharmaceuticals Inc Return on Equity|Catabasis Pharmaceuticals Inc Net Income (TTM) (USD)|Catabasis Pharmaceuticals Inc Revenue (TTM) (USD)|Catabasis Pharmaceuticals Inc Dividend Per Share (Quarterly) (USD)|Catabasis Pharmaceuticals Inc Revenue (Quarterly) (USD)|Catabasis Pharmaceuticals Inc Gross Profit (Quarterly) (USD)|Catabasis Pharmaceuticals Inc SG&A Expense (Quarterly) (USD)|Catabasis Pharmaceuticals Inc Pre-Tax Income (Quarterly) (USD)|Catabasis Pharmaceuticals Inc Net Income (Quarterly) (USD)|Catabasis Pharmaceuticals Inc Net Interest Income (Quarterly) (USD)|Catabasis Pharmaceuticals Inc Price (USD)|Catabasis Pharmaceuticals Inc Total Return Price (USD)|Catabasis Pharmaceuticals Inc Enterprise Value (USD)|Catabasis Pharmaceuticals Inc 30-Day Average Daily Volume|Catabasis Pharmaceuticals Inc 1 Year Price Returns (Daily)||
usamicro_0194|CATB|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
usamicro_0194|CATB|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|monthly|monthly|daily||
usamicro_0194|CATB|5|91.2727272727|91.2727272727|0|91.2727272727|0|91.2727272727|91.2727272727|91.2727272727|0|91.2727272727|91.2727272727|0|0|0|8.61504424779|91.2727272727|0|0|8.61504424779|0|92|1.78460128323|0|15.2301587302|0|91.2727272727|91.2727272727|0|0|31.1162790698|30.4509803922|0|30.5|91.32|341.2|91.32|33.5178571429|0|91.2727272727|0|92|91.32|91.3333333333|0|0|91.2727272727|0|0|92|0|91.32|91.32|91.32|91.32|8.61504424779|8.61504424779|8.61504424779|8.61990950226|6.97989949749||
usamicro_0194|CATB|6|22|22|0|22|0|22|22|22|0|22|22|0|0|0|226|11|0|0|226|0|1|1091|0|126|0|22|22|0|0|43|51|0|14|25|5|25|56|0|22|0|1|25|24|0|0|22|0|0|1|0|25|25|25|25|226|226|226|221|199||
usamicro_0194|CATB|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
usamicro_0194|CATB|201403||||||||||||||||||||||||||||||||||0.8665||-5.1573||||||-5.1573|||||||||1.373|-4.469|-4.469|0|||||||
usamicro_0194|CATB|201406||||||||||||||||||||||||||||||||||0.8665||-6.189||||||-6.189|0||||||||1.642|-5.363|-5.363|0|||||||
usamicro_0194|CATB|201409||||||||||||||||||||||||||||||||||0.8665||-6.953||||||-6.953|0||||||||1.427|-6.025|-6.025|-0.057|||||||
usamicro_0194|CATB|201412|15.022|14.668||0.288||89.017|4.234|84.783||-73.053|-75.38|||||||||||||||1.132|0.001|||||||0.8665||-6.9541|||1.3848|||-6.9541|0|||-21.883|||||1.552|-6.026|-6.026|-0.149|||||||
usamicro_0194|CATB|201503|24.854|24.303||0.26||13.238|4.993|8.245||13.487|-81.88|||||||||||||||2.021|0.01|||||||1.3848|34|-4.6939|||1.3848|||-4.6939||||-23.914|||||1.744|-6.5|-6.5|-0.149|||||||
usamicro_0194|CATB|201506|82.076|81.548||0.23||14.866|7.395|7.471||67.588|-89.92||||-0.1833||||1.4023|||0||0.1183||2.486|0.015|||||||0.0997||-80.7|1.5298||1.5298|||-80.7|-62.763|||-26.59|||||1.833|-8.039|-8.039|-0.279|13|13|4.2654|62813.2667||13.96|11.93
usamicro_0194|CATB|201509|73.3|72.709||0.216||14.113|7.411|6.702||59.544|-98.404||||2.5116||||0.2148|||0||0.2946||1.783|0.015|||||||1.5298||-5.5|1.5298||1.5298|||-5.5|0.987|||-29.05|||||2.388|-8.485|-8.485|-0.282|9.49|9.49|-60.2235|45793.4333||7.23|7.84
usamicro_0194|CATB|201512|63.552|62.78||0.504||13.676|7.779|5.897||50.493|-108.01||||1.8201||||0.2292|||0||1.0823||1.328|0.015|||||||1.5313|37|-6.3|1.5313||1.5313|||-6.3|0.032|||-32.63|||||2.663|-9.606|-9.606|-0.269|8.92|8.92|-49.3232|23447.3|||
usamicro_0194|CATB|201603|53.386|52.576||0.77||12.545|7.431|5.114||41.724|-117.428|||||||||||||2.0419||1.626|0.015|||||||1.5336||-6.1|1.5362||1.5362|||-6.1|0|||-35.548|||||2.77|-9.418|-9.418|-0.19|||||||
usamicro_0194|CATB|201606|43.729|42.817||0.718||11.746|7.422|4.324||32.814|-126.873|||||||||||||2.3632||1.559|0.015||||0.367|||1.5374||-6.1|1.5381||1.5381|||-6.1|0|||-36.954|||||2.578|-9.445|-9.445|-0.14|||||||
usamicro_0194|CATB|201609|48.299|47.267||0.641||12.079|8.541|3.538||36.861|-135.292|||||||||||||2.5434||1.721|0.019||||-0.7305|||1.5513||-5.4|1.8639||1.8639|||-5.4|-12.213|||-36.888|||||2.347|-8.419|-8.419|-0.149|||||||
usamicro_0194|CATB|201612|39.528|38.527||0.568||11.123|8.325|2.798||29.086|-144.07||||0.7564||||0.2614|||0||1.3081||1.405|0.019|||4|0|||1.8698|38|-4.5|1.8818||1.8818|||-4.5|0.219|||-36.06|||||2.413|-8.778|-8.778|-0.116|4.04|4.04|-25.2025|292392|-49.0542|1.2|
usamicro_0194|CATB|201703|32.815|31.795||0.494||9.467|7.496|1.971||23.955|-151.946||||0.8916||||0.1066|||0||8.6069||0.942|0.02|||1|-7.0764|||1.9093||-4.1|1.9997||1.9997|||-4.1|-2.215|||-34.518|||||2.363|-7.876|-7.876|-0.11|1.55|1.55|-29.7055|3148617.7|-79.8235|1.48|1.34
usamicro_0194|CATB|201706|30.261|29.369||0.442||9.266|8.129|1.137||21.55|-158.92||||0.7432||||0.1294|||0||4.3907||2.055|0.022|||1|-7.3069|||2.1796||-3.2|2.2482||2.2482|||-3.2|-4.086|||-32.047|||||2.4|-6.974|-6.974|-0.083|1.38|1.38|-23.7771|228108.0333|-82.5977|1.23|1.36
usamicro_0194|CATB|201709|22.812|21.713||0.388||7.656|7.559|0.097||15.657|-165.937||||0.7348|-0.5818|||0.1909||0.2105|0||0.7122||1.202|0.023|||1|-8.5488|||2.2563||-3.1|2.2895||2.2895||2.8725|-3.1|-0.609|||-30.645|||0.25||2.426|-7.017|-7.017|-0.06|1.83|1.83|-21.1458|622829.1|-76.9231|2.13|1.78
usamicro_0194|CATB|201712|17.463|16.369||0.321||6.105|6.016|0.089||11.792|-171.434||||0.5079|-0.5793|||0.227||0.2102|0||0.501||0.773|0.002|||1|-16.6308|||2.3235|36|-2.32|2.3645||2.3645||2.7209|-2.32|-1.126|||-27.364|||0.25||1.723|-5.497|-5.497|-0.049|1.54|1.54|-14.8622|192766.6333|-80.5801|1.49|1.72
usamicro_0194|CATB|201803|17.919|17.03||0.258||5.359|5.277|0.082||12.931|-179.086||||0.3221|-0.5653|||0.4432|||0||1.3824||1.115|0.029|||7|-1.5141|||2.6556||-2.88|2.9036||2.9036|||-2.88|-8.313|||-27.14|||||2.392|-7.652|-7.652|-0.025|1.8|1.8|-8.6635|925366.4|16.129|1.61|1.68
usamicro_0194|CATB|201806|50.683|49.931||0.051||5.035|4.961|0.074||45.812|-185.565||||0.3427|-2.3628|||0.5105|||0||1.0365||0.785|0.071|||8|-0.8233|||3.2729||-1.98|7.1038||7.1038|||-1.98|-39.325|||-26.645|||||2.397|-6.479|-6.479|0.01|0.9292|0.9292|-8.7723|872746.8333|-32.6667|0.7424|0.7967
usamicro_0194|CATB|201809|44.541|43.239||0.045||4.18|4.125|0.055||40.519|-191.244||||1.697|-2.0984|||0.1276|||0||1.6656||1.047|0.071|||2|-1.7893|||7.1038||-0.8|7.1038||7.1038|||-0.8|0.44|||-25.307|||||2.111|-5.679|-5.679|0.167|0.8226|0.8226|-43.2564|1221656.8667|-55.0492|0.6493|0.623
usamicro_0194|CATB|201812|38.915|37.57||0||4.227|4.171|0.056||34.942|-197.304||||1.6927|-0.3553|||0.0696|||0||0.8472||1.576|0.007|||1|-24.7138|||7.1381|24|-0.58|7.142||7.142|||-0.58|0.059|||-25.87|||||2.429|-6.06|-6.06|0.173|0.397|0.397|-40.3414|510510.6667|-72.6242|6.16|4.93
usamicro_0194|CATB|201903|52.649|51.664||1.625||4.628|4.298|0.33||49.869|-203.342||||-2.279|2.2007|||2.3984|||0||5.0097||1.588|0.011|||10|-23.646|||9.6862||-0.62|11.4962||11.4962|||-0.62|-20.68|||-24.256|||||2.137|-6.038|-6.038|0.226|7.29|7.29|53.4759|246768.0333|337.5691|8.12|6.88
usamicro_0194|CATB|201906|46.991|46.111||1.274||5.168|5.168|0||43.361|-210.473||||-1.4783|2.6333|||1.7547|||0||5.3507||1.41|0.012|||10|-16.4948||94.9335|11.5055||-0.62|11.5539||11.5539|||-0.62|-0.14|||-24.908|||||2.165|-7.131|-7.131|0.257|7.61|7.61|34.3463|111747.3333|687.3684|7.08|6.55
usamicro_0194|CATB|201909|42.726|40.615||0.965||5.561|5.561|0||38.273|-216.987||||-0.6069|1.2654|||1.4092|||0||3.9554||2.186|0.012|||10|-15.6837||94.9858|11.6242||-0.56|11.7153||11.7153|||-0.56|-0.974|||-25.743|||||1.985|-6.514|-6.514|0.214|5.26|5.26|14.1817|43972.3667|510.7319|5.1|5.32
usamicro_0194|CATB|201912|38.958|36.244||2.349||6.06|5.032|1.028||35.72|-223.597||||-1.4016|2.0807|||1.8063|||0||4.9359||1.237|0.012|||10|2.9333||68.8999|11.9589|27|-0.55|12.4336||12.4336|||-0.55|-3.772|||-26.293|||||2.484|-6.61|-6.61|0.148|5.86|5.86|37.2386|111614.2667|1376.0705|5.53|4.72
usamicro_0194|CATB|202003|57.14|55.103||1.799||5.465|4.59|0.875||53.711|-231.549||||-0.7108|1.0712|||2.0142|||0||1.8392||0.759|0.018|||7|1.1269||83.3261|15.8987||-0.5|17.8972||17.8972|||-0.5|-25.624|||-28.207|||||2.753|-7.952|-7.952|0.167|4.02|4.02|19.1704|195505.9|-43.6185|5.67|6.12
usamicro_0194|CATB|202006|55.598|53.886||1.326||6.227|5.509|0.718||50.86|-241.057||||-2.3379|3.752|||2.4824|||0||4.0536||1.212|0.019|||6|1.8295||88.8254|17.9675||-0.53|18.8236||18.8236|||-0.53|-6.265|||-30.584|||||2.803|-9.508|-9.508|0.06|7.45|7.45|67.1497|278523.3|-0.4011|5.9|6.72
usamicro_0194|CATB|202009|||||||||||||||-2.1829||||2.2922|||0||4.4264||||||7|1.6565||91.0827||||||||||||||||||||||6.01|6.01|62.6977|410721|15.7996|5.82|